European law changes mean drugmakers may have to grapple with generic competition soonernews2026-02-02T06:00:46+00:00February 2nd, 2026|Endpoints News|
IRA drug pricing petitions pile up at the Supreme Court news2026-01-26T20:21:13+00:00January 26th, 2026|Endpoints News|
High court picked Hikma’s ‘skinny label’ fight after letting the issue ‘percolate’ news2026-01-22T19:53:16+00:00January 22nd, 2026|Endpoints News|
Government funding bill features PBM reforms, voucher reauthorizationnews2026-01-20T19:14:42+00:00January 20th, 2026|Endpoints News|
Clinician groups ask court to overturn CDC’s childhood vaccine overhaulnews2026-01-20T15:54:25+00:00January 20th, 2026|Endpoints News|
Supreme Court will hear Hikma’s ‘skinny label’ fight against Amarinnews2026-01-16T20:06:44+00:00January 16th, 2026|Endpoints News|
New York sues ex-Emergent CEO over insider trading during vaccine manufacturing strugglenews2026-01-15T20:36:02+00:00January 15th, 2026|Endpoints News|
Congress’ biotech panel pitches FDA policy upgrades to help performancenews2026-01-13T05:01:10+00:00January 13th, 2026|Endpoints News|
HHS loses bid to suspend court block on 340B rebate pilotnews2026-01-08T15:57:49+00:00January 8th, 2026|Endpoints News|
Appeals court rules against NIH’s indirect cost cut plan news2026-01-05T23:54:56+00:00January 5th, 2026|Endpoints News|
